Clinipace Worldwide has completed the merger with Choice Pharma, a Pan-Asian CRO, extending its global footprint to include 20 operational offices in 15 countries, including new offices in Taiwan, China, Hong Kong, South Korea, Vietnam, Singapore, and Malaysia. According to the company, there are no layoffs or office closings planned. Terms of the transaction were not disclosed.

Back to News